Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

shaping the future

6 posts
NNovartis
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
Read More

Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases

  • 2026-06-06
Novartis Pharma AG New Cosentyx® (secukinumab) data from REPLENISH, largest ever global Phase III trial in polymyalgia rheumatica,…
NNovartis
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
Read More

Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases

  • 2026-06-03
Novartis Pharma AG New Cosentyx® (secukinumab) data from REPLENISH, largest ever global Phase III trial in polymyalgia rheumatica,…
NNovartis
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
Read More

Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases

  • 2026-06-01
Novartis Pharma AG New Cosentyx® (secukinumab) data from REPLENISH, largest ever global Phase III trial in polymyalgia rheumatica,…
NNestlé
Procurement Magazine’s Latest Issue Features Nestlé’s Chief Procurement Officer, Jacob Busk Nielson, on Global Volatility
Read More

Procurement Magazine’s Latest Issue Features Nestlé’s Chief Procurement Officer, Jacob Busk Nielson, on Global Volatility

  • 2026-02-18
The latest issue spotlights global leaders, breakthrough technologies and strategies shaping the future of resilience, global logistics, technology,…
NNestlé
Procurement Magazine’s Latest Issue Features Nestlé’s Chief Procurement Officer, Jacob Busk Nielson, on Global Volatility
Read More

Procurement Magazine’s Latest Issue Features Nestlé’s Chief Procurement Officer, Jacob Busk Nielson, on Global Volatility

  • 2026-02-15
The latest issue spotlights global leaders, breakthrough technologies and strategies shaping the future of resilience, global logistics, technology,…
NNestlé
Procurement Magazine’s Latest Issue Features Nestlé’s Chief Procurement Officer, Jacob Busk Nielson, on Global Volatility
Read More

Procurement Magazine’s Latest Issue Features Nestlé’s Chief Procurement Officer, Jacob Busk Nielson, on Global Volatility

  • 2026-02-12
The latest issue spotlights global leaders, breakthrough technologies and strategies shaping the future of resilience, global logistics, technology,…
Switzerland
www.europesays.com